Showing results (1-10 of 293) with videos related to
Sort By:
Pageof 30
Expert Review of Pharmacoeconomics & Outcomes Research|April 28, 2015
How do we value a cure?Don HusereauIssues in Emerging Health Technologies|December 21, 2002
Imatinib mesylate for chronic myeloid leukemia: what do we really know?Don HusereauApplied Health Economics and Health Policy|November 23, 2019
Systematic Review of Economic Evaluations of Services Provided by Community PharmacistsChiranjeev Sanyal, Don HusereauJournal of Vascular Surgery|October 17, 2012
Trends in the utilization of endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures in CanadaPrasad Jetty, Don HusereauInternational Journal of Technology Assessment in Health Care|July 5, 2022
Redefining Health Technology Assessment: A Comment on "The New Definition of Health Technology Assessment: A Milestone in International Collaboration"Anthony Culyer, Don HusereauEuropean Heart Journal|May 8, 2014
Statistical considerations in economic evaluations: a guide for cardiologistsShelby D ReedInternational Journal of Technology Assessment in Health Care|June 30, 2010
Priority setting for health technology assessment at CADTHDon Husereau, Michel Boucher, Hussein NooraniInternational Journal of Technology Assessment in Health Care|May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONSIlke Akpinar, Philip Jacobs, Don HusereauInternational Journal of Technology Assessment in Health Care|June 13, 2014
Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devicesDon Husereau, Chris Henshall, Jamil JivrajApplied Health Economics and Health Policy|February 8, 2018
Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for SwitchingDon Husereau, Brian Feagan, Carl Selya-HammerPageof 30